Navigation Links
Paul Chew Appointed to sanofi-aventis U.S. Chief Science Officer/Chief Medical Officer

BRIDGEWATER, N.J., March 16 /PRNewswire-FirstCall/ -- Sanofi-aventis U.S. announced today that Paul Chew, M.D., has been appointed to Chief Science Officer/Chief Medical Officer, U.S., effective April 1. He was previously President, R&D, sanofi-aventis, U.S.

As the company's Chief Science Officer and Chief Medical Officer, Paul Chew will establish a unified medical voice for sanofi-aventis U.S. among internal and external stakeholders. He will be responsible for overseeing U.S. Medical Affairs in addition to his continued oversight of the U.S. R&D organization in coordination with the Group in Paris. Further, Paul Chew will be charged with representing accurate and timely clinical and safety information to health authorities, payers, patients and physicians that will foster safe and appropriate use of our products.

Paul Chew's primary reporting will be to Greg Irace, President and Chief Executive Officer, sanofi-aventis U.S., in addition to Marc Cluzel, Group Senior Vice President of R&D and Jean-Pierre Lehner, Group Chief Medical Officer.

"Paul brings deep, scientific expertise and proven leadership to both the R&D and Medical functions in the U.S. - a critical area in which the science and the business of our industry intersect," said Greg Irace. "In this new role, Paul will be in a position to bring greater scientific and product insights to our organization, greater clarity and dialogue with members of the healthcare system and, ultimately, greater value to patients in the form of improved health outcomes."

The new role of Chief Science Officer/Chief Medical Officer is part of the company's overall organizational drive to ensure all components of the U.S. affiliate work in a coordinated manner to achieve harmonized processes, cost-effectiveness and best practice sharing in the design, conduct and monitoring of clinical studies.

About sanofi-aventis

Sanofi-aventis U.S. is an affiliate of sanofi-aventis, a leading global pharmaceutical company that discovers, develops and distributes therapeutic solutions to help improve the lives of patients. Sanofi-aventis is listed in Paris (EURONEXT: SAN) and in New York (NYSE: SNY).

For more information, or

    Media Contact:

    Lisa Buffington

SOURCE sanofi-aventis
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Dr. Jim Yong Kim Appointed 17th President of Dartmouth College
2. Industry Veterans Appointed to Key Leadership Posts at Healthcare Informatics Associates (HIA), an InfoLogix Company
3. Gregory J. Tibbitts Appointed Chief Financial Officer at Accumetrics, Inc.
4. Brickson Diamond Appointed Board Chair of National Hospice Foundation
5. Valensa Internationals Dr. Rudi E. Moerck Appointed CEO
6. Margaret Laub Appointed to IntelliDOT Board of Directors
7. Laurence Debroux Appointed Chief Strategic Officer (CSO)
8. Jean-Pierre Lehner Appointed Chief Medical Officer
9. Alice Stollenwerk Petrulis, MD, FACP, Appointed to NQF Care Coordination Committee
10. Former Assistant Secretary for Aging, The Honorable Josefina G. Carbonell, Appointed Senior Vice President at Independent Living Systems
11. Perrigo Company Appointed Generic Distributor by Medimetriks Pharmaceuticals
Post Your Comments:
(Date:11/26/2015)... , ... November 26, 2015 , ... Indosoft Inc., developer ... of an application server to improve system efficiency and reliability. , The new Q-Suite ... of these standards, the system avoids locking itself into a specific piece of software ...
(Date:11/25/2015)... Neb. (PRWEB) , ... November 25, 2015 , ... ... staffing companies, has been recognized once again for its stellar workplace culture with ... to Work.” , Medical Solutions’ Cincinnati office was named a finalist ...
(Date:11/25/2015)... ... November 25, 2015 , ... For the first time, Vitalalert is ... One Beat ” campaign. The partnership between the two groups began in 2014 with ... International’s cause. , MAP International was founded in 1954 and is an international Christian-based ...
(Date:11/25/2015)... (PRWEB) , ... November 25, 2015 , ... ... for physicians and athletic programs, launches new Wimbledon Athletics Facebook page ... testing young athletes for unsuspected cardiac abnormalities. About 2,000 people under the age ...
(Date:11/25/2015)... ... , ... Beddit® has launched a new Android app for use ... a more intuitive SleepScore™ that rates sleep quality on a 100-point scale and makes ... by a proprietary algorithm. Beddit analyzes the data to provide an easy to understand ...
Breaking Medicine News(10 mins):
(Date:11/26/2015)... FRANCISCO , November 26, 2015 ... billion by 2022, according to a new report by Grand ... Chronic Kidney Disease (CKD) which demands kidney transplantation is expected ... and cost effective substitute for organ transplantation. --> ... billion by 2022, according to a new report by Grand ...
(Date:11/26/2015)... 2015 ... the  "2016 Future Horizons and Growth ... Testing Market: Supplier Shares, Competitive Intelligence, ... --> ) has ... Future Horizons and Growth Strategies in ...
(Date:11/26/2015)... 2015 Research and Markets ( ) ... Care Market by Type (Dressings, Therapy Devices, Active Wound ... Out-Patient Facility), and Geography - Global Forecast to 2020" ... --> --> The purpose of this ... of the global advanced wound care market. It involves ...
Breaking Medicine Technology: